Search Results | MSF Science Portal

Journal Article

|

Research

Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, et al.

2023-06-01 • Lancet Global Health

BACKGROUND
Sputum is the most widely used sample to diagnose active tuberculosis, but many people living with HIV are unable to produce sputum. Urine, in contrast, is readily availab...

Journal Article

|

Research

Bonnet MMB, Gabillard D, Domoua SK, Muzoora C, Messou E, et al.

2023-03-08 • Clinical Infectious Diseases

BACKGROUND
In people with HIV (PWH), the WHO-recommended tuberculosis four-symptom screen (W4SS) targeting those who need molecular rapid test may be suboptimal. We assessed the perf...

Journal Article

|

Research

Laureillard D, Marcy O, Madec Y, Chea S, Chan S, et al.

2013-10-23 • AIDS

To analyze cases of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the CAMbodian Early versus Late Introduction of Antiretrovirals (CAMELIA)...

Journal Article

|

Research

Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al.

2011-10-20 • New England Journal of Medicine

Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation...

Journal Article

|

Research

Blanc FX, Badje AD, Bonnet MMB, Gabillard D, Messou E, et al.

2020-06-18 • New England Journal of Medicine

BACKGROUND
In regions with high burdens of tuberculosis and human immunodeficiency virus (HIV), many HIV-infected adults begin antiretroviral therapy (ART) when they are already seve...

Journal Article

|

Research

Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, et al.

2014-08-01 • Clinical Infectious Diseases

Shortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency vir...

Journal Article

|

Research

Migliori GB, Tiberi S, Zumla A, Petersen E, Chakaya JM, et al.

2020-02-01 • International Journal of Infectious Diseases

The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention and rehabilitation requires frequent update of existing guidelines. This review is aimed at provid...

Journal Article

|

Research

Borand L, Madec Y, Laureillard D, Chou M, Marcy O, et al.

2014-03-07 • PLOS One

OBJECTIVE
To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.

Science Portal

Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data

High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF® for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

Systematic or test-guided treatment for tuberculosis in HIV-infected adults

Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial

MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial)